CAS 89203-64-5

3-Pyrrolidineacetic acid

Description:

3-Pyrrolidineacetic acid, with the CAS number 89203-64-5, is an organic compound characterized by its pyrrolidine ring structure, which is a five-membered nitrogen-containing heterocycle. This compound features a carboxylic acid functional group, contributing to its acidic properties. It is typically a white to off-white solid at room temperature and is soluble in polar solvents such as water and alcohols, owing to the presence of the carboxylic acid group. The presence of the pyrrolidine ring imparts certain steric and electronic properties that can influence its reactivity and interactions with biological systems. 3-Pyrrolidineacetic acid may exhibit potential applications in pharmaceuticals, particularly in the development of compounds that target neurological or metabolic pathways. Its structural characteristics allow for various modifications, which can lead to derivatives with enhanced biological activity or specificity. As with many organic acids, it is important to handle this compound with care, observing appropriate safety protocols to mitigate any risks associated with its use.

Formula: C₆H₁₁NO₂

InChI: InChI=1/C6H11NO2/c8-6(9)3-5-1-2-7-4-5/h5,7H,1-4H2,(H,8,9)

SMILES: C1CNCC1CC(=O)O

Synonyms:

• Pyrrolidin-3-ylacetic acid
• 2-(Pyrrolidin-3-Yl)Acetic Acid
• 3-Pyrrolidineacetic acid

3-Pyrrolidineaceticacid

CAS: 89203-64-5

Formula: C₆H₁₁NO₂

Purity: 95%

Color and Shape: Solid

Molecular weight: 129.1570

Ref: IN-DA0036A5

3-Pyrrolidineacetic acid

CAS: 89203-64-5

3-Pyrrolidineacetic acid

Purity: ≥95%

Color and Shape: Solid

Molecular weight: 129.16g/mol

Ref: 54-OR47890

2-(Pyrrolidin-3-yl)acetic acid

CAS: 89203-64-5

Formula: C₆H₁₁NO₂

Purity: 95%

Molecular weight: 129.159

Ref: 10-F431454

3-Pyrrolidineaceticacid

CAS: 89203-64-5

3-Pyrrolidineacetic acid (3PA) is a drug with a broad range of pharmacological properties. It is a type of dpp-IV inhibitor, which blocks the enzyme that degrades the hormone erythropoietin. 3PA has also been shown to have anti-inflammatory effects, and it may be used in the treatment of autoimmune diseases. 3PA also shows significant cytotoxicity against colorectal adenocarcinoma cells and has been shown to inhibit angiogenesis. The drug binds to metal ions and forms an asymmetric complex with them, which then reacts with an allyl halide to form a chiral product. 3PA has been found to bind to GABA receptors in the brain and may be used as an analgesic for cardiac problems. The drug's hydroxyl group is responsible for its acidity, but it can also form complexes with other molecules such as acids or bases due to its acidic nature.

Formula: C₆H₁₁NO₂

Purity: Min. 95%

Molecular weight: 129.16 g/mol

Ref: 3D-FP150486